Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Systemic immunosuppression may prevent devastating complication in patients.
Yasha S. Modi, MD, discusses promising results from the VERONA study on EYP-1901, a potential treatment for diabetic macular edema.
Ophthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.
Procedure can improve best-corrected visual acuity, enhancing quality of life for patients.
The retina is a key proving ground for long-held theories of genetics.
A study reveals attrition rates in patients with geographic atrophy on complement inhibitor therapies, highlighting the need for improved treatment adherence strategies.
Need to eliminate errors results in optimization of training of novice surgeons.
EYP-1901 shows promising results in reducing treatment burden for diabetic macular edema, offering sustained improvements in vision and safety.
Dilraj S. Grewal, MD, FASRS, provides an in-depth overview of the current state of research and treatment innovations.
EyePoint Pharmaceuticals completes enrollment for the LUCIA trial, advancing DURAVYU's potential as a new treatment for wet AMD.
Deep Parikh, MD, sat down with Emily Kaiser Maharjan from Optometry Times to talk about his presentation at Collaborative Care Symposium on advanced treatments in neovascular retinal disease.
Working as an investigator can prove to be a positive experience for physicians
Kamran Riaz, MD, reviews a cataract surgery case where the patient was fitted with different IOLs in each eye.
At the EnVision Summit 2025 in San Juan, Puerto Rico, Tania Tai, Lucy Shen, and Shivani Kamat all gave insight into complications they have seen while performing glaucoma surgery.
A patient's vision loss leads to another diagnosis
In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations that defined modern ophthalmology.
Unlocking the potential of donor scleral tissue: Innovations and future applications.
New research reveals subretinal drusenoid deposits as potential indicators of serious heart disease, highlighting the need for ophthalmologists to screen patients effectively.
Optometry cochairs Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, OD, MA, FAAO, highlight the conference’s focus on collaboration, featuring topics like red flags for patient care, thyroid eye disease, and diabetes management.
One obvious trend has been that dry eye disease is a concurrent problem for virtually all my patients, and we need to address it for optimum comfort and surgical results.
Enhanced monofocal technology may benefit patients with cataracts and dry eye.
Through its ophthalmic program, Mercy Ships provides critical eye surgeries and trains local professionals, ensuring sustainable eye care for the future.
The Retina World Congress showcases global innovations in surgical and medical retina, highlighting emerging treatments and fostering collaboration among specialists.
Treatment of patients with COVID-19 should include ophthalmic considerations.